For instance, combining PI3K inhibitors, autophagy inhibitors, and immune checkpoint inhibitors presents a multifaceted attack on cancer cells, disrupting their survival pathways, metabolic processes, and immune evasion strategies. The gene discussed is PIK3CA; the disease is cancer.